长链非编码RNA NR_036444调控耐药骨肉瘤细胞对多柔比星的敏感性
该研究通过微阵列筛选发现,耐药MG63/DXR骨肉瘤细胞中lncRNA NR_036444表达下调22倍;过表达该lncRNA可降低多柔比星半数抑制浓度、诱导G1期阻滞和凋亡,且其在耐药组肿瘤组织中表达低于敏感组,低表达患者术后总生存期较短。
要点
- 耐药MG63/DXR细胞中lncRNA NR_036444表达较敏感MG63细胞下调22倍。
- 过表达组多柔比星半数抑制浓度为(5.77±0.25)μg/ml,较阴性对照组降低49.6%。
- 耐药组肿瘤组织lncRNA NR_036444表达为19.67±1.53,低于敏感组的77.67±2.52。
核心结论
- lncRNA NR_036444可能在调控骨肉瘤多柔比星耐药中起重要作用,未来可能作为评估化疗敏感性和预测骨肉瘤患者预后的生物标志物。
研究设计与样本
- 采用lncRNA-mRNA联合微阵列筛选多柔比星耐药MG63/DXR骨肉瘤细胞与配对多柔比星敏感MG63细胞的差异表达,并用qRT-PCR验证。
- 通过慢病毒在多柔比星耐药MG63/DXR细胞中过表达lncRNA NR_036444,用CCK-8法评估细胞增殖及对多柔比星的敏感性,用流式细胞术评估细胞周期和凋亡。
- 用qRT-PCR检测60例骨肉瘤患者手术切除肿瘤组织中lncRNA NR_036444的表达并进行相关性分析。
主要发现
- 随机选取15个lncRNA经qRT-PCR验证,其表达差异与微阵列结果一致。
- lncRNA NR_036444在MG63/DXR细胞中下调22倍,被确定为最显著的差异lncRNA。
- 空白组、阴性对照组和lncRNA NR_036444过表达组的半数抑制浓度分别为(12.73±0.50)μg/ml、(12.12±0.31)μg/ml和(5.77±0.25)μg/ml;过表达组较阴性对照组降低49.6%(P<0.001)。
- 过表达组、阴性对照组和空白组G1期细胞百分比分别为(90.12±0.08)%、(33.36±0.85)%和(39.38±1.02)%;过表达组G1期阻滞细胞显著多于阴性对照组和空白对照组(均P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the mechanism of long non-coding RNA (LncRNA) NR_036444 mediated sensitivity of multidrug-resistant osteosarcoma to doxorubicin. Methods: LncRNA-mRNA combined microarray was used to screen the differential expressions of lncRNA and mRNA in doxorubicin-resistant MG63/DXR osteosarcoma cells and their paired doxorubicin-sensitive MG63 cells; qRT-PCR was used to check the consistency of microarray. LncRNA NR_036444 was over-expressed in MG63/DXR cells by lentrvirus. CCK-8 array was used to evaluate cell proliferation and the sensitivity of cells to doxorubicin; Flow cytometry was used to evaluate cell cycle and apoptosis. The expressions of lncRNA NR_036444 in 60 cases of tumor tissues resected from osteosarcoma patients were detected by qRT-PCR and correlation analyses administrator were conducted. Results: Compared with those in MG63 cells, 1, 761 lncRNAs were significantly up-regulated and 1, 704 lncRNAs were dramatically down-regulated in MG63/DXR cells (P<0.05). 15 lncRNAs were selected randomly and their expressions were confirmed by qRT-PCR. The data showed that the differences in expression of 15 lncRNAs were consistent with microarray result. lncRNA NR_036444 with 22 folds down-regulation was identified as the most significant differential lncRNA in MG63/DXR cells. Half maximal inhibitory concentrations (IC(50)) in the blank group, negative control group and lncRNA NR_036444 overexpressed group were (12.73±0.50) μg/ml、(12.12±0.31) μg/ml and (5.77±0.25) μg/ml, respectively. Compared with that in negative control group, IC(50) in overexpressed group decreased by 49.6% (P<0.001). The percentages of G(1) phase cells in the overexpressed group, negative control group and blank group were(90.12±0.08)%, (33.36±0.85)% and (39.38±1.02)%. Compared with the negative control group and blank control group, the overexpression group had significantly more cells arrested in G(1) phase (both P<0.001). In the overexpressed group, negative control group and blank group, the percentages of late-apoptotic cells were (11.40±1.08)%, (4.23±1.12)% and (0.28±0.12)%, respectively. The percentages of early-apoptotic cells were (86.40±1.80)%, (4.35±2.03)% and (0.25±0.02) %, respectively. The percentages of early- and late-apoptotic cells were significantly increased in the overexpressed group when compared with those in control groups (P<0.01). Meanwhile, the expression of lncRNA NR_036444 in the tissues of chemoresistance group and chemosensitivity group was 19.67±1.53 and 77.67±2.52, respectively, with a statistically significant difference (P<0.01). The postoperative overall survival time of osteosarcoma patients with low expression of lncRNA NR_036444 was (24.6±2.4) months, significantly shorter than (48.2±1.8) months of patients with high expression of lncRNA NR_036444 (P<0.001). Conclusions: LncRNA NR_036444 may play a vital role in regulating osteosarcoma doxorubicin resistance and it may be a useful biomarker to assess the chemosensitivity and predict the prognosis of osteosarcoma patients in the future.
引用
- Zhu KP, Zhang CL. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444]. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28550663. doi:10.3760/cma.j.issn.0253-3766.2017.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。